Back to User profile » Dr Xiao Li
Papers published by Dr Xiao Li:
Circ_0001944 Targets the miR-1292-5p/FBLN2 Axis to Facilitate Sorafenib Resistance in Hepatocellular Carcinoma by Impeding Ferroptosis
Jing F, Shi Y, Jiang D, Li X, Sun J, Guo Q
ImmunoTargets and Therapy 2024, 13:643-659
Published Date: 26 November 2024
Involvement of the ABCB1 C3435T Variant but Not the MTHFR C677T or MTHFR A1298C Variant in High-Dose Methotrexate-Induced Toxicity in Pediatric Acute Lymphoblastic Leukemia Patients in China
Guo Q, Sun JL, Li R, Li X
International Journal of General Medicine 2024, 17:1221-1231
Published Date: 27 March 2024
Prediction of Unbound Vancomycin Levels in Intensive Care Unit and Nonintensive Care Unit Patients: Total Bilirubin May Play an Important Role
Li X, Xu W, Li R, Guo Q, Li X, Sun J, Sun S, Li J
Infection and Drug Resistance 2021, 14:2543-2554
Published Date: 2 July 2021
Identifying risk factors for high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia
Li X, Sui Z, Jing F, Xu W, Li X, Guo Q, Sun S, Bi X
Cancer Management and Research 2019, 11:6265-6274
Published Date: 5 July 2019
Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery
Li X, Sui Z, Li X, Xu W, Guo Q, Sun J, Jing F
International Journal of Nanomedicine 2018, 13:3053-3067
Published Date: 25 May 2018
Efficacy and mechanism of tanshinone IIA liquid nanoparticles in preventing experimental postoperative peritoneal adhesions in vivo and in vitro
Qin F, Ma Y, Li X, Wang X, Wei Y, Hou C, Lin S, Hou L, Wang C
International Journal of Nanomedicine 2015, 10:3699-3717
Published Date: 21 May 2015
Sulfatide-containing lipid perfluorooctylbromide nanoparticles as paclitaxel vehicles targeting breast carcinoma
Li X, Qin F, Yang L, Mo LQ, Li L, Hou LB
International Journal of Nanomedicine 2014, 9:3971-3985
Published Date: 18 August 2014